Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
September 24, 2024 08:01 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Company to host conference call today at 8.30 a.m. ETContinued progress within core activities in RNA delivery, supported by move into new...
Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024
September 20, 2024 09:01 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA...
Odysight.ai Reports Financial Results for the First Half of 2024 and Provides Business Update
August 15, 2024 08:30 ET
|
Odysight.ai Inc.
OMER, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (OTCQB: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions,...
BioCorRx Reports Business Update for the Second Quarter of 2024
August 15, 2024 08:30 ET
|
BioCorRx Inc
ANAHEIM, CA, Aug. 15, 2024 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today...
Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update
August 14, 2024 16:30 ET
|
Biofrontera Inc.
Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today...
IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update
August 14, 2024 08:00 ET
|
Imunon, Inc.
Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development...
Evaxion Announces Business Update and Second Quarter 2024 Financial Results
August 14, 2024 07:00 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines,...
BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update
August 13, 2024 16:05 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 13, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem...
Palisade Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
August 13, 2024 08:05 ET
|
Palisade Bio, Inc.
– Continued progress toward commencement of Phase 1 human clinical study of lead product candidate, PALI-2108, for the treatment of Ulcerative Colitis (UC) before year end – Company continues to...
Bitech Technologies Announces Business Update and Provides Key 2024 Milestones for BESS Projects
August 12, 2024 07:30 ET
|
Bitech Technologies Corporation
Recent Solar Portfolio Divestment Provides Substantial Capital Infusion to Execute on BESS Rollout Nasdaq Uplisting On Track Newport Beach, CA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Bitech...